Please Wait.....
Report
Patient Monitoring Devices Market by Product (EEG, MEG, TCD, Pulse Oximeter, Spirometer, Fetal Monitor, Temperature Monitor, MCOT, ECG, ICP, ILRs, Multi-parameter Monitoring, Weight Monitoring), End-User (Hospital, ASCs) - Global Forecast to 2027
Market Report I 2022-09-21 I 378 Pages I MarketsandMarkets
The patient monitoring devices market is anticipated to grow at a CAGR of 9.1% to reach USD 65.4 billion by 2027 from USD 42.3 billion in 2022. The growth of the market is mainly attributed to greater adoption of biosensors and connected care devices and higher demand for home-based or home-use products. However, the high cost associated with novel and advanced monitoring devices is expected to limit the market growth.
In product segment, blood glucose monitoring systems segment will undergo a significant growth by 2027.
Based on the product, the patient monitoring devices market is segmented into multiparameter monitoring devices, temperature monitoring devices, blood glucose monitoring systems, fetal and neonatal monitoring devices, neuromonitoring devices, weight monitoring devices, cardiac monitoring devices, hemodynamic/pressure monitoring devices, respiratory monitoring devices, and other patient monitoring devices. The substantial growth of the segment is attributed to the technological advancements and ongoing product approval of continuous glucose monitoring systems, benefits offered by continuous monitoring systems over self-monitoring systems in the market. Continuous glucose monitoring systems offer a wide range of advantages over self-monitoring blood glucose systems, such as non-invasive detection shortened detection time, and reduced cost. These advantages among several other advantages offered by the continuous glucose monitoring systems will lead to the growth of this product segment.
By end-user hospitals segment is anticipated to account for the major share of the patient monitoring devices market,
By end-users, the patient monitoring devices market is segmented into home care settings, hospitals, ambulatory surgery centers, and other end users. The demand growth among hospitals is attributed to the momentous availability of state-of-the-art services for patient treatment, diagnosis, as well as trained personnel, and disease management, that has ensured a stable demand for increasing number of hospitals in major countries and the hospital-based care. More diagnostic and screening procedures are carried out in hospitals, promoting to the increased market share. The influx of patients is usually higher in hospitals as compared to other healthcare settings, which is another key driver for segment growth.
By Region, Asia Pacific Patient Monitoring Devices Market is anticipated to grow at the highest CAGR by 2027.
The Asia Pacific market will grow at the highest CAGR during the forecast period majorly due to the rising healthcare expenditure, heavy burden of infectious diseases, and increasing geriatric population along with favourable public and private contribution to overall healthcare infrastructure. Apart from this, the increase in the number of ambulatory surgical centers and development of infrastructure in hospitals the APAC region is expected to propel the patient monitoring devices market.
A breakdown of the primary participants referred to for this report is provided below:
- By Company Type: Tier 1-45%, Tier 2-34%, and Tier 3- 21%
- By Designation: C-level-47%, Director-level-33%, and Others-20%
- By Region: North America-35%, Europe-32%, Asia Pacific-25%, Latin America-6%, and the Middle East & Africa-2%
List of Companies Profiled in the Report
o Abbott Laboratories (US),
o HILL-ROM HOLDINGS, INC. (US),
o Dragerwerk AG & Co. KGaA (Germany),
o Edwards Lifesciences Corporation (US),
o OMRON Corporation (Japan),
o Masimo Corporation (US),
o Compumedics Limited (Australia),
o Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China),
o Nihon Kohden Corporation (Japan),
o Natus Medical (US), Medtronic plc (Ireland),
o Koninklijke Philips N.V. (Netherlands),
o GE Healthcare (US), Getinge AB (Sweden),
o Boston Scientific Corporation (US),
o Dexcom, Inc. (US),
o Nonin (US),
o BIOTRONIK (Germany),
o SCHILLER (Switzerland),
o BioTelemetry, Inc. (US)
Research Coverage
This report studies the patient monitoring devices market based on product, end user, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).
Reasons to Buy the Report
The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.
This report provides insights on the following pointers:
- Market Penetration: Comprehensive information on the product portfolios offered by the top players in the patient monitoring devices market
- Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the patient monitoring devices market
- Market Development: Comprehensive information on lucrative emerging regions
- Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the patient monitoring devices market
- Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.
1 INTRODUCTION 45
1.1 STUDY OBJECTIVES 45
1.2 MARKET DEFINITION 45
TABLE 1 INCLUSIONS AND EXCLUSIONS 45
1.3 STUDY SCOPE 46
FIGURE 1 PATIENT MONITORING DEVICES MARKET 46
FIGURE 2 PATIENT MONITORING DEVICES MARKET, BY GEOGRAPHY 46
1.4 YEARS CONSIDERED 47
1.5 CURRENCY CONSIDERED 47
1.6 STAKEHOLDERS 47
1.7 SUMMARY OF CHANGES 48
2 RESEARCH METHODOLOGY 49
2.1 RESEARCH DATA 49
2.2 RESEARCH DESIGN 49
FIGURE 3 PATIENT MONITORING DEVICES MARKET: RESEARCH DESIGN 49
2.2.1 SECONDARY DATA 50
2.2.2 PRIMARY DATA 51
FIGURE 4 PRIMARY SOURCES 51
2.2.2.1 Key data from primary sources 52
2.2.2.2 Insights from primary experts 52
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND DEMAND SIDE PARTICIPANTS 53
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 53
2.3 MARKET SIZE ESTIMATION 54
FIGURE 7 SUPPLY SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 54
FIGURE 8 TOP-DOWN APPROACH 55
2.4 DATA TRIANGULATION 57
FIGURE 9 DATA TRIANGULATION METHODOLOGY 57
2.5 MARKET SHARE ESTIMATION 58
2.6 RESEARCH ASSUMPTIONS 58
2.7 LIMITATIONS 58
2.8 RISK ASSESSMENT 59
TABLE 2 LIMITATIONS AND ASSOCIATED RISKS 59
3 EXECUTIVE SUMMARY 60
FIGURE 10 PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION) 60
FIGURE 11 PATIENT MONITORING DEVICES MARKET, BY END USER, 2022 VS. 2027 (USD MILLION) 61
FIGURE 12 ASIA PACIFIC MARKET TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 62
4 PREMIUM INSIGHTS 63
4.1 PATIENT MONITORING DEVICES MARKET OVERVIEW 63
FIGURE 13 TECHNOLOGICAL ADVANCEMENTS AND RISING DISEASE INCIDENCE TO DRIVE DEMAND FOR PATIENT MONITORING DEVICES 63
4.2 ASIA PACIFIC: PATIENT MONITORING DEVICES MARKET SHARE, BY COUNTRY & PRODUCT 64
FIGURE 14 JAPAN HOLDS LARGEST HIGHEST SHARE OF APAC MARKET 64
4.3 PATIENT MONITORING DEVICES MARKET SHARE, BY END USER 65
FIGURE 15 HOSPITALS TO ACCOUNT FOR LARGEST MARKET SHARE DURING 2022-2027 65
4.4 GEOGRAPHICAL SNAPSHOT OF THE PATIENT MONITORING DEVICES MARKET 65
FIGURE 16 MARKET IN CHINA TO GROW AT HIGHEST RATE DURING 2022-2027 65
5 MARKET OVERVIEW 66
5.1 INTRODUCTION 66
5.2 MARKET DYNAMICS 66
FIGURE 17 PATIENT MONITORING DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 66
5.2.1 DRIVERS 67
5.2.1.1 Increasing technological advancements and innovations 67
5.2.1.1.1 Increased user-centric designs for wearable devices 67
5.2.1.1.2 Growing use of non-invasive hemodynamic monitoring 68
5.2.1.1.3 Rising use of digital data sensors 68
5.2.1.1.4 Growing use of mobile-grade EEG devices 69
5.2.1.2 Rising prevalence of chronic diseases 69
5.2.1.3 Availability of wireless monitoring devices 71
TABLE 3 RECENT PRODUCT INNOVATIONS IN PATIENT MONITORING DEVICES MARKET 72
5.2.1.4 Growing preference for wearable patient monitoring devices, biosensors, and smart implants 72
5.2.1.5 Growing investments, funds, and grants in healthcare systems 73
5.2.2 RESTRAINTS 74
5.2.2.1 Risks associated with invasive monitoring devices 74
5.2.2.2 High cost of patient monitoring products and inadequate reimbursement 75
5.2.3 OPPORTUNITIES 75
5.2.3.1 Increasing demand for non-invasive and minimally invasive devices 75
5.2.3.2 Growing demand for patient monitoring devices in non-hospital settings 76
5.2.4 CHALLENGES 76
5.2.4.1 Lack of skilled healthcare professionals 76
5.2.4.2 Increased pricing pressure on market players 77
5.3 VALUE CHAIN ANALYSIS 78
FIGURE 18 VALUE CHAIN ANALYSIS-MAXIMUM VALUE ADDED DURING MANUFACTURING PHASE 78
5.4 ECOSYSTEM ANALYSIS 79
5.5 REGULATORY ANALYSIS 79
5.5.1 NORTH AMERICA 79
5.5.1.1 US 79
TABLE 4 US FDA: MEDICAL DEVICE CLASSIFICATION 80
TABLE 5 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 80
5.5.1.2 Canada 80
TABLE 6 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 81
FIGURE 19 CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES 81
5.5.2 EUROPE 82
FIGURE 20 EUROPE: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES (MDR) 83
5.5.3 ASIA PACIFIC 84
5.5.3.1 Japan 84
TABLE 7 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 84
5.5.3.2 China 85
TABLE 8 CHINA: CLASSIFICATION OF MEDICAL DEVICES 85
5.5.3.3 India 86
5.6 TRADE ANALYSIS 87
TABLE 9 IMPORT DATA FOR PATIENT MONITORS (HS CODE 901890), BY COUNTRY, 2017- 2021 (USD MILLION) 87
TABLE 10 EXPORT DATA FOR PATIENT MONITORS (HS CODE 901890), BY COUNTRY, 2017- 2021 (USD MILLION) 87
5.7 KEY CONFERENCES AND EVENTS IN 2022-2023 88
TABLE 11 DETAILED LIST OF MAJOR CONFERENCES AND EVENTS 88
6 PATIENT MONITORING DEVICES MARKET, BY PRODUCT 89
6.1 INTRODUCTION 90
TABLE 12 PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 90
6.2 BLOOD GLUCOSE MONITORING SYSTEMS 91
TABLE 13 BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION) 91
TABLE 14 BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY REGION, 2020-2027 (USD MILLION) 91
TABLE 15 BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2020-2027 (USD MILLION) 92
6.2.1 SELF-MONITORING BLOOD GLUCOSE SYSTEMS 92
6.2.1.1 Rising adoption of integrated glucose monitoring systems to drive growth 92
TABLE 16 SELF-MONITORING BLOOD GLUCOSE SYSTEMS MARKET, BY REGION, 2020-2027 (USD MILLION) 93
6.2.2 CONTINUOUS GLUCOSE MONITORING SYSTEMS 94
6.2.2.1 Product launches and evolving reimbursement scenarios for continuous monitoring systems to drive market growth 94
TABLE 17 CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY REGION, 2020-2027 (USD MILLION) 95
6.3 CARDIAC MONITORING DEVICES 95
TABLE 18 CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 95
TABLE 19 CARDIAC MONITORING DEVICES MARKET, BY REGION, 2020-2027 (USD MILLION) 96
TABLE 20 CARDIAC MONITORING DEVICES MARKET, BY END USER, 2020-2027 (USD MILLION) 96
6.3.1 ECG DEVICES 97
6.3.1.1 Low cost and wide applications of ECG devices to drive market growth 97
TABLE 21 ECG DEVICES MARKET, BY REGION, 2020-2027 (USD MILLION) 98
6.3.2 IMPLANTABLE LOOP RECORDERS 98
6.3.2.1 High cost and limited applications limit growth 98
TABLE 22 IMPLANTABLE LOOP RECORDERS MARKET, BY REGION, 2020-2027 (USD MILLION) 99
6.3.3 EVENT MONITORS 99
6.3.3.1 Emergence of portable and wireless event monitors to drive market growth 99
TABLE 23 EVENT MONITORS MARKET, BY REGION, 2020-2027 (USD MILLION) 100
6.3.4 MCT MONITORS 100
6.3.4.1 Availability of alternate technologies likely to hinder market growth 100
TABLE 24 MCT MONITORS MARKET, BY REGION, 2020-2027 (USD MILLION) 101
6.3.5 SMART/WEARABLE ECG MONITORS 101
6.3.5.1 Need to minimize treatment costs for CVD patients to increase adoption of smart/wearable ECG monitors 101
TABLE 25 SMART/WEARABLE ECG MONITORS OFFERED BY MARKET PLAYERS 102
TABLE 26 SMART/WEARABLE ECG MONITORS MARKET, BY REGION, 2020-2027 (USD MILLION) 103
6.4 MULTI-PARAMETER MONITORING DEVICES 103
TABLE 27 MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 103
TABLE 28 MULTI-PARAMETER MONITORING DEVICES MARKET, BY REGION, 2020-2027 (USD MILLION) 104
TABLE 29 MULTI-PARAMETER MONITORING DEVICES MARKET, BY END USER, 2020-2027 (USD MILLION) 104
6.4.1 LOW-ACUITY MONITORING DEVICES 104
6.4.1.1 Increasing adoption of low-acuity monitoring devices to improve care in general wards drives market growth 104
TABLE 30 LOW-ACUITY MONITORING DEVICES MARKET, BY REGION, 2020-2027 (USD MILLION) 105
6.4.2 MID-ACUITY MONITORING DEVICES 105
6.4.2.1 Rising geriatric population is likely to increase market growth 105
TABLE 31 MID-ACUITY MONITORING DEVICES MARKET, BY REGION, 2020-2027 (USD MILLION) 105
6.4.3 HIGH-ACUITY MONITORING DEVICES 106
6.4.3.1 Increasing partnerships between manufacturers and hospitals drive device sales 106
TABLE 32 HIGH-ACUITY MONITORING DEVICES MARKET, BY REGION, 2020-2027 (USD MILLION) 106
6.5 RESPIRATORY MONITORING DEVICES 106
TABLE 33 RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 107
TABLE 34 RESPIRATORY MONITORING DEVICES MARKET, BY REGION, 2020-2027 (USD MILLION) 107
TABLE 35 RESPIRATORY MONITORING DEVICES MARKET, BY END USER, 2020-2027 (USD MILLION) 108
6.5.1 PULSE OXIMETERS 108
6.5.1.1 Rising adoption of pulse oximeters in home care settings to drive market growth 108
TABLE 36 PULSE OXIMETERS MARKET, BY REGION, 2020-2027 (USD MILLION) 109
6.5.2 SPIROMETERS 109
6.5.2.1 Technological advancements to increase the adoption of spirometers 109
TABLE 37 SPIROMETERS MARKET, BY REGION, 2020-2027 (USD MILLION) 110
6.5.3 CAPNOGRAPHS 110
6.5.3.1 Product development and growing commercial acceptance to drive market growth 110
TABLE 38 CAPNOGRAPHS MARKET, BY REGION, 2020-2027 (USD MILLION) 111
6.5.4 PEAK FLOW METERS 111
6.5.4.1 Low preference for peak flow meters due to high variability in measurements from different devices hinders market growth 111
TABLE 39 PEAK FLOW METERS MARKET, BY REGION, 2020-2027 (USD MILLION) 112
6.6 TEMPERATURE MONITORING DEVICES 112
TABLE 40 TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 112
TABLE 41 TEMPERATURE MONITORING DEVICES MARKET, BY REGION, 2020-2027 (USD MILLION) 113
TABLE 42 TEMPERATURE MONITORING DEVICES MARKET, BY END USER, 2020-2027 (USD MILLION) 113
6.6.1 HANDHELD TEMPERATURE MONITORING DEVICES 113
6.6.1.1 Advantages associated with handheld temperature monitoring devices to drive market growth 113
TABLE 43 HANDHELD TEMPERATURE MONITORING DEVICES OFFERED BY MARKET PLAYERS 114
TABLE 44 HANDHELD TEMPERATURE MONITORING DEVICES MARKET, BY REGION, 2020-2027 (USD MILLION) 115
6.6.2 TABLE-TOP TEMPERATURE MONITORING DEVICES 115
6.6.2.1 Increasing risks associated with hypothermia during surgeries to drive demand for table-top devices 115
TABLE 45 TABLE-TOP TEMPERATURE MONITORING DEVICES MARKET, BY REGION, 2020-2027 (USD MILLION) 116
6.6.3 WEARABLE CONTINUOUS MONITORING DEVICES 116
6.6.3.1 Versatile functionalities offered by wearable continuous monitoring devices to drive demand 116
TABLE 46 WEARABLE CONTINUOUS MONITORING DEVICES OFFERED BY MARKET PLAYERS 117
TABLE 47 WEARABLE CONTINUOUS MONITORING DEVICES MARKET, BY REGION, 2020-2027 (USD MILLION) 117
6.6.4 INVASIVE TEMPERATURE MONITORING DEVICES 118
6.6.4.1 Risk of bloodstream infections associated with catheter usage hinders market for invasive devices 118
TABLE 48 INVASIVE TEMPERATURE MONITORING DEVICES MARKET, BY REGION, 2020-2027 (USD MILLION) 118
6.6.5 SMART TEMPERATURE MONITORING PATCHES 119
6.6.5.1 Long-term monitoring capabilities of smart patches to drive market growth 119
TABLE 49 SMART TEMPERATURE MONITORING PATCHES OFFERED BY MARKET PLAYERS 119
TABLE 50 SMART TEMPERATURE MONITORING PATCHES MARKET, BY REGION, 2020-2027 (USD MILLION) 120
6.7 HEMODYNAMIC/PRESSURE MONITORING DEVICES 120
TABLE 51 HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 120
TABLE 52 HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY REGION, 2020-2027 (USD MILLION) 121
TABLE 53 HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY END USER, 2020-2027 (USD MILLION) 121
6.7.1 HEMODYNAMIC MONITORS 122
6.7.1.1 Influx of VC funding to drive market growth 122
TABLE 54 HEMODYNAMIC MONITORS MARKET, BY REGION, 2020-2027 (USD MILLION) 122
6.7.2 BLOOD PRESSURE MONITORS 123
6.7.2.1 Development of wearable blood pressure monitors to drive market growth 123
TABLE 55 WEARABLE BLOOD PRESSURE MONITORS OFFERED BY MARKET PLAYERS 123
TABLE 56 BLOOD PRESSURE MONITORS MARKET, BY REGION, 2020-2027 (USD MILLION) 124
6.7.3 DISPOSABLES 124
6.7.3.1 Growing number of surgical procedures to drive growth in disposables market 124
TABLE 57 HEMODYNAMIC/PRESSURE MONITORING DISPOSABLES MARKET, BY REGION, 2020-2027 (USD MILLION) 124
6.8 FETAL & NEONATAL MONITORING DEVICES 125
TABLE 58 FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 125
TABLE 59 FETAL & NEONATAL MONITORING DEVICES MARKET, BY REGION, 2020-2027 (USD MILLION) 125
TABLE 60 FETAL & NEONATAL MONITORING DEVICES MARKET, BY END USER, 2020-2027 (USD MILLION) 126
6.8.1 FETAL MONITORING DEVICES 126
6.8.1.1 Rising prevalence of obstetric complications, growing pre-term birth rate drive market growth 126
TABLE 61 WEARABLE FETAL MONITORING & OBSTETRIC DEVICES OFFERED BY MARKET PLAYERS 128
TABLE 62 FETAL MONITORING DEVICES MARKET, BY REGION, 2020-2027 (USD MILLION) 128
6.8.2 NEONATAL MONITORING DEVICES 128
6.8.2.1 Rising number of neonatal care facilities worldwide to drive market 128
TABLE 63 NEONATAL MONITORING DEVICES MARKET, BY REGION, 2020-2027 (USD MILLION) 129
6.9 NEUROMONITORING DEVICES 129
TABLE 64 NEUROMONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 130
TABLE 65 NEUROMONITORING DEVICES MARKET, BY REGION, 2020-2027 (USD MILLION) 130
TABLE 66 NEUROMONITORING DEVICES MARKET, BY END USER, 2020-2027 (USD MILLION) 131
6.9.1 EEG MACHINES 131
6.9.1.1 Growing applications and technological advancements form key market growth drivers 131
TABLE 67 EEG MACHINES MARKET, BY REGION, 2020-2027 (USD MILLION) 132
6.9.2 EMG MACHINES 132
6.9.2.1 Availability of reimbursements for EMG-assisted surgeries boosts product demand 132
TABLE 68 EMG MACHINES MARKET, BY REGION, 2020-2027 (USD MILLION) 133
6.9.3 CEREBRAL OXIMETERS 133
6.9.3.1 Growing cases of hypoxia during surgical procedures to drive market growth 133
TABLE 69 CEREBRAL OXIMETERS MARKET, BY REGION, 2020-2027 (USD MILLION) 134
6.9.4 ICP MONITORS 134
6.9.4.1 Growing incidence of post-surgical cerebrovascular complications and TBIs support adoption of ICP monitors 134
TABLE 70 ICP MONITORS MARKET, BY REGION, 2020-2027 (USD MILLION) 135
6.9.5 MEG MACHINES 135
6.9.5.1 High implementation and maintenance costs of MEG devices likely to hinder market growth 135
TABLE 71 MEG MACHINES MARKET, BY REGION, 2020-2027 (USD MILLION) 136
6.9.6 TCD MACHINES 136
6.9.6.1 Rising prevalence of strokes and cerebrovascular disorders will contribute to market growth 136
TABLE 72 TCD MACHINES MARKET, BY REGION, 2020-2027 (USD MILLION) 136
6.10 WEIGHT MONITORING DEVICES 137
TABLE 73 WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 137
TABLE 74 WEIGHT MONITORING DEVICES MARKET, BY REGION, 2020-2027 (USD MILLION) 137
TABLE 75 WEIGHT MONITORING DEVICES MARKET, BY END USER, 2020-2027 (USD MILLION) 138
6.10.1 DIGITAL WEIGHT MONITORING DEVICES 138
6.10.1.1 Consumer preference for digital scales-a key market driver 138
TABLE 76 DIGITAL WEIGHT MONITORING DEVICES MARKET, BY REGION, 2020-2027 (USD MILLION) 138
6.10.2 ANALOG WEIGHT MONITORING DEVICES 139
6.10.2.1 Rising prevalence of obesity and low cost of analog scales support market growth 139
TABLE 77 ANALOG WEIGHT MONITORING DEVICES MARKET, BY REGION, 2020-2027 (USD MILLION) 139
6.11 OTHER PATIENT MONITORING DEVICES 140
TABLE 78 POLYSOMNOGRAPHY DEVICES OFFERED BY VARIOUS PLAYERS 140
TABLE 79 WEARABLE SLEEP MONITORING DEVICES OFFERED BY MARKET PLAYERS 141
TABLE 80 OTHER PATIENT MONITORING DEVICES MARKET, BY REGION, 2020-2027 (USD MILLION) 141
TABLE 81 OTHER PATIENT MONITORING DEVICES MARKET, BY END USER, 2020-2027 (USD MILLION) 142
7 PATIENT MONITORING DEVICES MARKET, BY END USER 143
7.1 INTRODUCTION 144
TABLE 82 PATIENT MONITORING DEVICES MARKET, BY END USER, 2020-2027 (USD MILLION) 144
7.2 HOSPITALS 144
7.2.1 HOSPITALS TO DOMINATE END-USER MARKET 144
TABLE 83 PATIENT MONITORING DEVICES MARKET FOR HOSPITALS, BY REGION, 2020-2027 (USD MILLION) 145
7.3 AMBULATORY SURGERY CENTERS 145
7.3.1 COST-EFFECTIVENESS AND CONVENIENCE DRIVE DEMAND FOR AMBULATORY CARE 145
TABLE 84 PATIENT MONITORING DEVICES MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2020-2027 (USD MILLION) 146
7.4 HOME CARE SETTINGS 146
7.4.1 REDUCED COST AND CONTINUOUS MONITORING OF VITAL INFORMATION IN HOME SETTINGS TO BOOST GROWTH 146
TABLE 85 PATIENT MONITORING DEVICES MARKET FOR HOME CARE SETTINGS, BY REGION, 2020-2027 (USD MILLION) 147
7.5 OTHER END USERS 147
TABLE 86 PATIENT MONITORING DEVICES MARKET FOR OTHER END USERS, BY REGION, 2020-2027 (USD MILLION) 148
8 PATIENT MONITORING DEVICES MARKET, BY REGION 149
8.1 INTRODUCTION 150
TABLE 87 PATIENT MONITORING DEVICES MARKET, BY REGION, 2020-2027 (USD MILLION) 150
8.2 NORTH AMERICA 151
FIGURE 21 NORTH AMERICA: PATIENT MONITORING DEVICES MARKET SNAPSHOT 151
TABLE 88 NORTH AMERICA: PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 152
TABLE 89 NORTH AMERICA: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 152
TABLE 90 NORTH AMERICA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION) 153
TABLE 91 NORTH AMERICA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 153
TABLE 92 NORTH AMERICA: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 154
TABLE 93 NORTH AMERICA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 154
TABLE 94 NORTH AMERICA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 155
TABLE 95 NORTH AMERICA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 155
TABLE 96 NORTH AMERICA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 156
TABLE 97 NORTH AMERICA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 156
TABLE 98 NORTH AMERICA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 157
TABLE 99 NORTH AMERICA: PATIENT MONITORING DEVICES MARKET, BY END USER, 2020-2027 (USD MILLION) 157
8.2.1 US 157
8.2.1.1 Growing number of FDA approvals for patient monitoring devices to support market growth 157
TABLE 100 VC FUNDING IN THE PATIENT MONITORING DEVICES MARKET IN THE US 158
TABLE 101 US: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 159
TABLE 102 US: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION) 159
TABLE 103 US: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 160
TABLE 104 US: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 160
TABLE 105 US: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 160
TABLE 106 US: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 161
TABLE 107 US: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 161
TABLE 108 US: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 162
TABLE 109 US: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 162
TABLE 110 US: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 162
8.2.2 CANADA 163
8.2.2.1 Growing public-private funding for research to drive market growth 163
TABLE 111 RESEARCH GRANTS IN THE PATIENT MONITORING DEVICES MARKET IN CANADA 163
TABLE 112 RECENT DEVELOPMENTS IN THE CANADIAN PATIENT MONITORING DEVICES MARKET 164
TABLE 113 CANADA: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 165
TABLE 114 CANADA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION) 166
TABLE 115 CANADA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 166
TABLE 116 CANADA: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 167
TABLE 117 CANADA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 167
TABLE 118 CANADA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 168
TABLE 119 CANADA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 168
TABLE 120 CANADA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 169
TABLE 121 CANADA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 169
TABLE 122 CANADA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 169
8.3 EUROPE 170
TABLE 123 PRODUCT APPROVALS IN THE EUROPEAN PATIENT MONITORING DEVICES MARKET 170
TABLE 124 EUROPE: PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 170
TABLE 125 EUROPE: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 171
TABLE 126 EUROPE: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION) 171
TABLE 127 EUROPE: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 172
TABLE 128 EUROPE: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 172
TABLE 129 EUROPE: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 173
TABLE 130 EUROPE: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 173
TABLE 131 EUROPE: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 174
TABLE 132 EUROPE: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 174
TABLE 133 EUROPE: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 175
TABLE 134 EUROPE: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 175
TABLE 135 EUROPE: PATIENT MONITORING DEVICES MARKET, BY END USER, 2020-2027 (USD MILLION) 176
8.3.1 GERMANY 176
8.3.1.1 Rising healthcare expenditure and manufacturer expansion to boost market growth 176
TABLE 136 GERMANY: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 177
TABLE 137 GERMANY: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION) 178
TABLE 138 GERMANY: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 178
TABLE 139 GERMANY: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 179
TABLE 140 GERMANY: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 179
TABLE 141 GERMANY: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 180
TABLE 142 GERMANY: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 180
TABLE 143 GERMANY: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 181
TABLE 144 GERMANY: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 181
TABLE 145 GERMANY: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 181
8.3.2 UK 182
8.3.2.1 Increasing public & private investments contribute to market growth 182
TABLE 146 UK: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 183
TABLE 147 UK: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION) 183
TABLE 148 UK: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 184
TABLE 149 UK: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 184
TABLE 150 UK: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 185
TABLE 151 UK: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 185
TABLE 152 UK: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 186
TABLE 153 UK: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 186
TABLE 154 UK: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 187
TABLE 155 UK: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 187
8.3.3 FRANCE 187
8.3.3.1 Statutory health insurance system to support market growth 187
TABLE 156 FRANCE: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 188
TABLE 157 FRANCE: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION) 189
TABLE 158 FRANCE: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 189
TABLE 159 FRANCE: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 190
TABLE 160 FRANCE: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 190
TABLE 161 FRANCE: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 191
TABLE 162 FRANCE: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 191
TABLE 163 FRANCE: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 192
TABLE 164 FRANCE: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 192
TABLE 165 FRANCE: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 192
8.3.4 ITALY 193
8.3.4.1 Rising incidence of lifestyle diseases to drive adoption of patient monitoring devices 193
TABLE 166 ITALY: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 194
TABLE 167 ITALY: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION) 195
TABLE 168 ITALY: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 195
TABLE 169 ITALY: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 196
TABLE 170 ITALY: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 196
TABLE 171 ITALY: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 197
TABLE 172 ITALY: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 197
TABLE 173 ITALY: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 198
TABLE 174 ITALY: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 198
TABLE 175 ITALY: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 199
8.3.5 SPAIN 199
8.3.5.1 Growing number of surgical procedures to drive market growth in Spain 199
TABLE 176 SPAIN: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 200
TABLE 177 SPAIN: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION) 201
TABLE 178 SPAIN: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 201
TABLE 179 SPAIN: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 202
TABLE 180 SPAIN: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 202
TABLE 181 SPAIN: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 203
TABLE 182 SPAIN: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 203
TABLE 183 SPAIN: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 204
TABLE 184 SPAIN: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 204
TABLE 185 SPAIN: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 205
8.3.6 REST OF EUROPE 205
TABLE 186 KEY MERGERS & ACQUISITIONS AND PARTNERSHIPS IN THE PATIENT MONITORING DEVICES MARKET IN THE ROE 205
TABLE 187 ROE: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 206
TABLE 188 ROE: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION) 207
TABLE 189 ROE: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 207
TABLE 190 ROE: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 208
TABLE 191 ROE: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 208
TABLE 192 ROE: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 209
TABLE 193 ROE: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 209
TABLE 194 ROE: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 210
TABLE 195 ROE: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 210
TABLE 196 ROE: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 211
8.4 ASIA PACIFIC 211
FIGURE 22 ASIA PACIFIC: PATIENT MONITORING DEVICES MARKET SNAPSHOT 212
TABLE 197 ASIA PACIFIC: PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 213
TABLE 198 ASIA PACIFIC: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 214
TABLE 199 ASIA PACIFIC: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION) 215
TABLE 200 ASIA PACIFIC: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 215
TABLE 201 ASIA PACIFIC: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 216
TABLE 202 ASIA PACIFIC: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 216
TABLE 203 ASIA PACIFIC: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 217
TABLE 204 ASIA PACIFIC: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 217
TABLE 205 ASIA PACIFIC: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 218
TABLE 206 ASIA PACIFIC: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 218
TABLE 207 ASIA PACIFIC: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 218
TABLE 208 ASIA PACIFIC: PATIENT MONITORING DEVICES MARKET, BY END USER, 2020-2027 (USD MILLION) 219
8.4.1 JAPAN 219
8.4.1.1 Large geriatric population and favorable reimbursement scenario to support market growth 219
TABLE 209 RECENT DEVELOPMENTS IN THE PATIENT MONITORING DEVICES MARKET IN JAPAN 220
TABLE 210 JAPAN: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 221
TABLE 211 JAPAN: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION) 222
TABLE 212 JAPAN: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 222
TABLE 213 JAPAN: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 223
TABLE 214 JAPAN: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 223
TABLE 215 JAPAN: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 224
TABLE 216 JAPAN: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 224
TABLE 217 JAPAN: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 225
TABLE 218 JAPAN: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 225
TABLE 219 JAPAN: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 225
8.4.2 CHINA 226
8.4.2.1 Growing focus of local and international market players on this market 226
TABLE 220 RECENT DEVELOPMENTS IN THE PATIENT MONITORING DEVICES MARKET IN CHINA 226
TABLE 221 CHINA: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 227
TABLE 222 CHINA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION) 228
TABLE 223 CHINA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 228
TABLE 224 CHINA: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 229
TABLE 225 CHINA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 229
TABLE 226 CHINA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 230
TABLE 227 CHINA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 230
TABLE 228 CHINA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 231
TABLE 229 CHINA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 231
TABLE 230 CHINA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 231
8.4.3 INDIA 232
8.4.3.1 Increasing government-implemented healthcare initiatives to support market growth 232
TABLE 231 INDIA: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 233
TABLE 232 INDIA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION) 234
TABLE 233 INDIA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 234
TABLE 234 INDIA: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 235
TABLE 235 INDIA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 235
TABLE 236 INDIA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 236
TABLE 237 INDIA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 236
TABLE 238 INDIA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 237
TABLE 239 INDIA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 237
TABLE 240 INDIA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 237
8.4.4 AUSTRALIA 238
8.4.4.1 R&D Tax Incentive Program to support market growth 238
TABLE 241 AUSTRALIA: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 239
TABLE 242 AUSTRALIA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION) 240
TABLE 243 AUSTRALIA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 240
TABLE 244 AUSTRALIA: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 241
TABLE 245 AUSTRALIA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 241
TABLE 246 AUSTRALIA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 242
TABLE 247 AUSTRALIA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 242
TABLE 248 AUSTRALIA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 243
TABLE 249 AUSTRALIA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 243
TABLE 250 AUSTRALIA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 244
8.4.5 SOUTH KOREA 244
8.4.5.1 Supportive government initiatives to drive market growth 244
TABLE 251 SOUTH KOREA: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 245
TABLE 252 SOUTH KOREA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION) 246
TABLE 253 SOUTH KOREA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 246
TABLE 254 SOUTH KOREA: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 247
TABLE 255 SOUTH KOREA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 247
TABLE 256 SOUTH KOREA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 248
TABLE 257 SOUTH KOREA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 248
TABLE 258 SOUTH KOREA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 249
TABLE 259 SOUTH KOREA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 249
TABLE 260 SOUTH KOREA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 249
8.4.6 REST OF ASIA PACIFIC 250
TABLE 261 RECENT DEVELOPMENTS IN THE PATIENT MONITORING DEVICES MARKET IN ROAPAC 250
TABLE 262 ROAPAC: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 251
TABLE 263 ROAPAC: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION) 252
TABLE 264 ROAPAC: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 252
TABLE 265 ROAPAC: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 253
TABLE 266 ROAPAC: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 253
TABLE 267 ROAPAC: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 254
TABLE 268 ROAPAC: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 254
TABLE 269 ROAPAC: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 255
TABLE 270 ROAPAC: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 255
TABLE 271 ROAPAC: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 255
8.5 LATIN AMERICA 256
TABLE 272 LATAM: PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 256
TABLE 273 LATAM: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 257
TABLE 274 LATAM: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION) 258
TABLE 275 LATAM: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 258
TABLE 276 LATAM: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 259
TABLE 277 LATAM: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 259
TABLE 278 LATAM: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 260
TABLE 279 LATAM: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 260
TABLE 280 LATAM: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 261
TABLE 281 LATAM: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 261
TABLE 282 LATAM: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 262
TABLE 283 LATAM: PATIENT MONITORING DEVICES MARKET, BY END USER, 2020-2027 (USD MILLION) 262
8.5.1 BRAZIL 262
8.5.1.1 Brazil to dominate LATAM market 262
TABLE 284 BRAZIL: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 263
TABLE 285 BRAZIL: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION) 264
TABLE 286 BRAZIL: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 264
TABLE 287 BRAZIL: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 264
TABLE 288 BRAZIL: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 265
TABLE 289 BRAZIL: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 265
TABLE 290 BRAZIL: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 266
TABLE 291 BRAZIL: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 266
TABLE 292 BRAZIL: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 267
TABLE 293 BRAZIL: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 267
8.5.2 MEXICO 267
8.5.2.1 Favorable investment scenario for medical device manufacturers to drive market growth 267
TABLE 294 MEXICO: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 268
TABLE 295 MEXICO: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION) 269
TABLE 296 MEXICO: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 269
TABLE 297 MEXICO: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 269
TABLE 298 MEXICO: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 270
TABLE 299 MEXICO: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 270
TABLE 300 MEXICO: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 271
TABLE 301 MEXICO: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 271
TABLE 302 MEXICO: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 272
TABLE 303 MEXICO: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 272
8.5.3 REST OF LATIN AMERICA 272
TABLE 304 ROLATAM: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 274
TABLE 305 ROLATAM: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION) 275
TABLE 306 ROLATAM: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 275
TABLE 307 ROLATAM: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 276
TABLE 308 ROLATAM: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 276
TABLE 309 ROLATAM: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 277
TABLE 310 ROLATAM: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 277
TABLE 311 ROLATAM: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 278
TABLE 312 ROLATAM: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 278
TABLE 313 ROLATAM: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 278
8.6 MIDDLE EAST & AFRICA 279
8.6.1 AWARENESS INITIATIVES TO DRIVE ADOPTION OF PATIENT MONITORING DEVICES IN THE REGION 279
TABLE 314 MEA: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 280
TABLE 315 MEA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION) 280
TABLE 316 MEA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 281
TABLE 317 MEA: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 281
TABLE 318 MEA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 282
TABLE 319 MEA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 282
TABLE 320 MEA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 283
TABLE 321 MEA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 283
TABLE 322 MEA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 284
TABLE 323 MEA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 284
TABLE 324 MEA: PATIENT MONITORING DEVICES MARKET, BY END USER, 2020-2027 (USD MILLION) 284
9 COMPETITIVE LANDSCAPE 285
9.1 OVERVIEW 285
9.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 285
9.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN PATIENT MONITORING DEVICES MARKET 286
9.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 287
FIGURE 23 REVENUE ANALYSIS OF KEY PLAYERS IN PATIENT MONITORING DEVICES MARKET 287
9.4 COMPETITIVE BENCHMARKING OF TOP 26 PLAYERS 288
TABLE 325 OVERALL COMPANY FOOTPRINT 288
TABLE 326 COMPANY PRODUCT FOOTPRINT 289
TABLE 327 COMPANY END-USER FOOTPRINT 291
TABLE 328 COMPANY REGIONAL FOOTPRINT 292
9.5 COMPANY EVALUATION QUADRANT 293
9.5.1 STARS 294
9.5.2 EMERGING LEADERS 294
9.5.3 PERVASIVE PLAYERS 294
9.5.4 PARTICIPANTS 294
FIGURE 24 PATIENT MONITORING DEVICES: COMPETITIVE LEADERSHIP MAPPING (2021) 295
9.6 COMPANY EVALUATION QUADRANT FOR START-UPS/SMES 296
9.6.1 PROGRESSIVE COMPANIES 296
9.6.2 DYNAMIC COMPANIES 296
9.6.3 STARTING BLOCKS 296
9.6.4 RESPONSIVE COMPANIES 296
FIGURE 25 PATIENT MONITORING DEVICES MARKET: COMPETITIVE LEADERSHIP MAPPING FOR STARTUP COMPANIES (2021) 297
9.7 KEY STAKEHOLDERS AND BUYING CRITERIA 298
9.7.1 KEY STAKEHOLDERS IN BUYING PROCESS 298
FIGURE 26 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR PATIENT MONITORING DEVICES 298
TABLE 329 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR PATIENT MONITORING DEVICES 298
9.7.2 BUYING CRITERIA 298
FIGURE 27 KEY BUYING CRITERIA FOR PATIENT MONITORING DEVICES 298
TABLE 330 KEY BUYING CRITERIA FOR PATIENT MONITORING DEVICES 299
9.8 MARKET RANKING ANALYSIS 299
FIGURE 28 LEADING PLAYERS IN PATIENT MONITORING DEVICES MARKET (2021) 300
9.9 COMPETITIVE SCENARIO 300
9.9.1 PRODUCT LAUNCHES & APPROVALS 300
TABLE 331 PRODUCT LAUNCHES & APPROVALS, 2020-2022 301
9.9.2 ALLIANCES, PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS 304
TABLE 332 ALLIANCES, PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS, 2019-2020 304
9.9.3 MERGERS & ACQUISITIONS 307
TABLE 333 MERGERS & ACQUISITIONS, 2017-2020 307
9.9.4 EXPANSIONS 308
TABLE 334 EXPANSIONS, 2017-2020 308
10 COMPANY PROFILES 309
10.1 KEY PLAYERS 309
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
10.1.1 GE HEALTHCARE 309
TABLE 335 GE HEALTHCARE: COMPANY OVERVIEW 309
FIGURE 29 GE HEALTHCARE: COMPANY SNAPSHOT (2021) 310
10.1.2 MEDTRONIC PLC 313
TABLE 336 MEDTRONIC PLC: COMPANY OVERVIEW 313
FIGURE 30 MEDTRONIC PLC: COMPANY SNAPSHOT (2021) 314
10.1.3 KONINKLIJKE PHILIPS N.V. 320
TABLE 337 KONINKLIJKE PHILIPS: COMPANY OVERVIEW 320
FIGURE 31 KONINKLIJKE PHILIPS: COMPANY SNAPSHOT (2021) 321
10.1.4 ABBOTT LABORATORIES 328
TABLE 338 ABBOTT LABORATORIES: COMPANY OVERVIEW 328
FIGURE 32 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2021) 329
10.1.5 NIHON KOHDEN CORPORATION 332
TABLE 339 NIHON KOHDEN CORPORATION: COMPANY OVERVIEW 332
FIGURE 33 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT (2021) 333
10.1.6 MASIMO CORPORATION 338
TABLE 340 MASIMO CORPORATION: COMPANY OVERVIEW 338
FIGURE 34 MASIMO CORPORATION: COMPANY SNAPSHOT (2021) 338
10.1.7 OMRON CORPORATION 345
TABLE 341 OMRON CORPORATION: COMPANY OVERVIEW 345
FIGURE 35 OMRON CORPORATION: COMPANY SNAPSHOT (2021) 346
10.1.8 EDWARDS LIFESCIENCES CORPORATION 350
TABLE 342 EDWARDS LIFESCIENCES CORPORATION: COMPANY OVERVIEW 350
FIGURE 36 EDWARDS LIFESCIENCES CORPORATION: COMPANY SNAPSHOT (2021) 351
10.1.9 HILL-ROM HOLDINGS 353
TABLE 343 HILL-ROM HOLDINGS: COMPANY OVERVIEW 353
FIGURE 37 HILL-ROM HOLDINGS, INC.: COMPANY SNAPSHOT (2021) 354
10.1.10 DRAGERWERK AG & CO. KGAA 358
TABLE 344 DRAGERWERK AG & CO. KGAA: COMPANY OVERVIEW 358
FIGURE 38 DRAGERWERK: COMPANY SNAPSHOT (2021) 359
10.1.11 NATUS MEDICAL 361
TABLE 345 NATUS MEDICAL: COMPANY OVERVIEW 361
FIGURE 39 NATUS MEDICAL: COMPANY SNAPSHOT (2021) 362
10.1.12 GETINGE AB 365
TABLE 346 GETINGE AB: COMPANY OVERVIEW 365
FIGURE 40 GETINGE AB: COMPANY SNAPSHOT (2021) 366
10.1.13 COMPUMEDICS LIMITED 367
TABLE 347 COMPUMEDICS LIMITED: COMPANY OVERVIEW 367
FIGURE 41 COMPUMEDICS LIMITED: COMPANY SNAPSHOT (2021) 367
10.1.14 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS 370
TABLE 348 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS: COMPANY OVERVIEW 370
10.1.15 NONIN 373
TABLE 349 NONIN: COMPANY OVERVIEW 373
10.1.16 RECENT DEVELOPMENTS 374
?
10.2 OTHER COMPANIES 375
10.2.1 BIOTRONIK 375
10.2.2 BOSTON SCIENTIFIC CORPORATION 375
10.2.3 BIOTELEMETRY 376
10.2.4 SCHILLER 377
10.2.5 DEXCOM 378
10.2.6 SENSEONICS 378
10.2.7 CARDIOMO 379
10.2.8 VITLS 379
10.2.9 NETEERA 380
10.2.10 TYTO CARE 380
10.2.11 QARDIO 381
10.2.12 EJENTA 381
10.2.13 VIVIFY HEALTH 382
10.2.14 NOTEWORTH 382
10.2.15 IRHYTHM TECHNOLOGIES, INC. 383
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
11 APPENDIX 384
11.1 DISCUSSION GUIDE 384
11.2 KNOWLEDGESTORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL 388
11.3 AVAILABLE CUSTOMIZATION OPTIONS 390
11.4 RELATED REPORTS 390
11.5 AUTHOR DETAILS 391
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security